Connect Biopharma Holdings (CNTB)

• Market cap: $84.7M
• 1 day: 0%
• 5 days: -8.43%
• 1 month: -16.48%
• 3 months: -25.85%
• 6 months: 89.43%
• Year to date: 25.62%
• 1 year: 44.76%
• 5 years: -91.78%
• 10 years: -91.78%
• Sector: Healthcare
• Industry: Biotechnology

About: Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Employees: 62